NYSE:CHEHealthcare
What Chemed (CHE)'s Lowered Guidance and EPS Miss Means For Shareholders
Chemed Corporation recently reported adjusted second-quarter 2025 earnings per share that missed analyst expectations and lowered its full-year revenue and earnings guidance.
An important insight is that this disappointing update also caused analyst sentiment to turn more negative, with consensus forecasts revised downward.
We'll explore how management's reduced guidance and softer financial outlook could reshape Chemed’s long-term investment narrative and growth assumptions.
We've found 19...